• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Incoming St. Jude Medical CEO Rousseau shuffles the deck

Incoming St. Jude Medical CEO Rousseau shuffles the deck

September 14, 2015 By Brad Perriello

St. Jude Medical CEO Michael RousseauThe incoming chief executive at St. Jude Medical (NYSE:STJ) isn’t even in the corner office yet, but Michael Rousseau isn’t letting any grass grow under his feet.

Rousseau, who’s slated to succeed longtime CEO Daniel Starks next year, announced a slate of executive changes today, elevating 1 senior vice president to the executive committee and expanding the purviews of several others, effective Jan 1, 2016.

Little Canada, Minn.-based St. Jude said it promoted Phil Eberling from senior vice president of R&D for electrophysiology & cardiovascular to vice president and chief technology officer and gave him a seat on the company’s executive committee.

Group president Dr. Eric Fain is slated to add responsibility for global sales & marketing to his clinical oversight duties, with chief marketing officer Lisa Andrade; Americas sales president Joel Becker; global clinical affairs VP Dr. Mark Carlson; and international sales president Denis Gestin all reporting to Fain.

CFO Don Zurbay is due to take on the investor relations role and oversee CIO Mark Murphy. General counsel Jason Zellers was given responsibility for St. Jude’s quality organization, overseeing global quality VP Jeffry Fecho.

Global communications vice president Rachel Ellingson was named VP of corporate strategy, keeping her PR duties and adding business development and M&A integration to her duties; John Heinmiller will stay on as executive vice president to “focus his efforts in a senior advisory capacity to help ensure a seamless leadership transition,” a St. Jude spokeswoman told MassDevice.com via email today.

 

Paul Bae and Scott Thome are slated to keep their roles as vice president of HR & chief compliance officer and global operations VP, respectively.

“We are fortunate to have an executive team that’s uniquely qualified to continue St. Jude Medical’s growth story,” Rousseau said in prepared remarks. “This is a remarkable team with a diverse set of experiences and a proven track record that will allow us to continue to transform and diversify the way we develop medical technologies in order to improve the care for patients around the world. Over the past several years, our executive team has made significant contributions to the business and shares in the excitement of the future of St. Jude Medical.”

Filed Under: Business/Financial News Tagged With: Personnel Moves, stjudemedical

More recent news

  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech
  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy
  • Elucent Medical wins FDA breakthrough nod for in-body spatial intelligence system
  • EndoQuest Robotics completes first cases in pivotal surgical robot trial
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy